Nestled in the heart of Charlotte, North Carolina, the Carolina Fish Market has earned a well-deserved reputation for offering not only the freshest and sustainably sourced seafood but also for its commitment to combating the pressing issue of overfishing. In a world grappling with the dwindling populations of wild fish, this market has become a beacon of hope by advocating responsible seafood choices and championing the concept of farmed fish as a viable solution.
At the forefront of their mission is a strong belief in educating customers about the benefits of responsibly farmed fish. Just as people embrace farm-raised meat, fruits, and vegetables on a daily basis, the Carolina Fish Market strives to dispel misconceptions and encourage consumers to consider responsibly farmed seafood as an alternative that ensures a stable supply while preserving the delicate balance of our oceans’ ecosystems.
One of the key sources for the market’s farmed fish is the picturesque Faroe Islands, located in the North Atlantic. Renowned for their unwavering commitment to sustainable aquaculture practices, the Faroe Islands have set an example for the world. It is here that the Carolina Fish Market finds its exceptional supply of salmon, a jewel of the seas.
What sets the Faroe Islands apart is their dedication to stringent regulations that prioritize the well-being of the fish and the preservation of the surrounding environment. Low-density farms provide ample space for the salmon to swim, resulting in fish with firm flesh and unparalleled flavor. To ensure the utmost quality, the Carolina Fish Market goes the extra mile by flying in fresh salmon daily, delivering sushi-grade freshness that tantalizes even the most discerning palates.
Beyond the delectable taste and quality, the market’s choice to partner with responsible fish farms aligns with their commitment to supporting local economies and reducing their carbon footprint. By selecting farmed fish from trusted sources like the Faroe Islands, the market contributes to the prosperity of coastal communities while minimizing the environmental impact associated with long-distance fishing operations.
The Carolina Fish Market’s efforts to promote sustainable seafood practices and responsible choices extend far beyond their local reach. Through their dedication to sourcing responsibly and delivering the finest, freshest fish, they serve as an example for the entire industry, urging consumers to make informed and sustainable seafood choices.
In a world where the oceans face unprecedented challenges, the Carolina Fish Market in Charlotte, North Carolina, is a shining example of how businesses can champion sustainability and make a positive impact. By embracing the exceptional qualities of farmed fish, such as the renowned salmon from the Faroe Islands, this market not only satisfies appetites but also helps preserve our oceans for future generations. So, the next time you visit the Carolina Fish Market, rest assured that you are indulging in a delicious meal while supporting a cause that goes far beyond the plate.
Carolina Fish Market Doug Shrute 704-458-1011 https://carolinafishmarket.com/
A spokesman for the Food and Environmental Hygiene Department (FEHD) said that Po On Road Market in Sham Shui Po is undergoing inspection and maintenance works and the services of individual stalls are affected.
After receiving the report from a stall tenant this morning (April 15) on a suspected fallen hanging jet fan, the FEHD had cordoned off the area nearby and informed the officers of Architectural Services Department (ArchSD) and the Electrical and Mechanical Services Department (EMSD) for follow-up investigation. Initial investigation revealed that the incident did not involve structural safety problem, and no injury or property loss was caused. As a precautionary measure, the ArchSD and the EMSD officers had inspected relevant electrical and mechanical equipment in Po On Road Market, and removed some of the installations. The departments will continue to follow up on the inspection and maintenance works.
St. Peter’s Episcopal Church will host its annual fundraiser, The Market at 3 West Ridge, from Tuesday, February 7 through Thursday, February 9 at 3 West Ridge Road on Skidaway Island.
This year’s event will benefit Heads-Up Guidance Services (HUGS) and People of Action Caring for Kids (P.A.C.K.), two local non-profit organizations dedicated to improving the health and welfare of Savannah’s children at risk. Proceeds from the $5 entrance fee (good for all three days), individual and corporate sponsorships, plant sales, and 15% of vendor sales will be divided between HUGS and P.A.C.K.
The Market at 3 West Ridge consists of a boutique trunk show and plant sale. The trunk show features unique merchandise and apparel from vendors across the country. Shoppers can also purchase annuals, perennials, hanging baskets, and containers at the plant sale with the additional opportunity to pre-order a wide assortment of early spring plants with a March pick-up date.
“Our affordable and accessible behavioral health counseling services rely solely on community donations and dedicated professional clinical volunteers,” explained HUGS founder and managing director, Andrea Epting. “Thanks to the proceeds from The Market, HUGS can continue to provide these crucial and essential services to at-risk children in our community.”
The Market at 3 West Ridge will be open on Tuesday, February 7 from 5:00 to 7:30 p.m. (wine & light hors d’oeuvres), Wednesday, February 8 from 10:00 a.m. to 5:00 p.m., and Thursday, February 9 from 10:00 a.m. to 4:00 p.m. For more information about the fundraiser, visit saintpeterssav.org/the-market.
About Heads-Up Guidance Services (HUGS) Founded in 2009, Heads-Up Guidance Services (HUGS) is a non-profit organization making professional behavioral health counseling and addiction recovery services accessible to all motivated individuals who desire growth, independence, and emotionally healthy lifestyles. HUGS provides counseling for those located throughout Savannah, Brunswick, Bluffton, and beyond. HUGS’ services are made both affordable and possible thanks to community donations and dedicated professional clinical volunteers. For more information, visit headsupsavannah.org.
Heads Up Guidance Services Katie Cupp (847) 450-3886 https://www.headsupsavannah.org/
S.A.F. Special Steel PCL (SET: SAF), one of Thailand’s leaders in high-grade steel supplies and vacuum hardening services, today made a trading debut on the Stock Exchange of Thailand (SET) Market for Alternative Investment (MAI). SAF’s entry in the industrial products segment came on the heels of a successful initial public offering (IPO) of 80 million shares at 1.93 baht per share.
SAF’s leadership in special grade steel, and potential to grow with target industries, and the management team’s experience and vision will make SAF a quality stock for the Thai capital market. [Image: SAF]
Mr Pisit Ariyadejwanich, Chief Executive Officer of SAF hailed the SET Market for Alternative Investment (MAI) debut as a crucial milestone in the firm’s 30-year-plus history, marking a new chapter in business expansion. “This is an important step and the pride of the management, team members, and all stakeholders who have contributed to this remarkable success,” he said.
With the MAI listing, SAF is targeting growth in the country’s three main industries, namely automotive parts, construction materials, and food. It is prepared to expand by building the new warehouse and setting up the nitriding furnace system, as well as seek growth opportunities in the CLMV countries which includes Cambodia, Laos, Myanmar, and Vietnam.
SAF is ready to capitalize on its experience and expertise of more than three decades in the sales of special-grade steel and providing vacuum heat treatment services. SAF has been entrusted as the distributor of high-quality special steel from leading German brands such as DORRENBERG EDELSTAHL GmbH and WILHELM OBERSTE-BEULMANN GmbH.
The company is committed to delivering innovative products and high-quality services, improving the efficiency of human resources and completing operational processes, as well as following good Environmental, Social, and Governance (ESG) guidelines.
The three key industrial sectors that SAF will focus on, with potentially significant growth are: – Automotive parts industry using special grade steel to make molds and dies to produce parts for automobiles, motorcycles, as well as agricultural machinery vehicles – Construction materials industry using special grade steel to make dies to produce aluminium profiles for window and door frames, machinery parts in the production of cement and steel for construction works – Food industry using special grade steel to make molds and dies to produce pans, pots, LPG cylinders, cans, and packaging bottles, and machinery parts in the sugar cane production process, and so on
The company will focus on expanding its customer base by offering hardening services together with mold steel selling, launching new products, and participating in bidding for various public and private projects.
Concurrently, SAF is also looking for opportunities to expand into ‘New S-curve’ industries such as electric vehicles (EV), as well as expanding its business to CLMV countries.
Furthermore, SAF will seek authorization from German partners to be the exclusive distributor of special grade steel products in those countries.
In addition, the company has targeted on achieving an annual growth rate of 23-28% during 2023 to 2024 in line with the increased inventory capacity and the addition of nitriding hardening services, of which, enable SAF to respond to customers better and more comprehensively.
Miss Veeraya Sriwattana, Head of Investment Banking CGS-CIMB Securities (Thailand) Co., Ltd., lead underwriter of the SAF new share issue, said the firm’s MAI listing would boost its business potential and enhance capital strength to support the business expansion plan. According to the company’s goals, this consists of increasing its warehousing capacity to 4,000 tonnes, with the expansion of the SAF3 warehouse, and investing in a nitriding furnace system to provide a one-stop hardening service for industrial customers.
She also said that with SAF’s leadership in the business of special grade steel, the potential to grow continuously along with the targeted industries, and the management team’s vision and experience will make SAF a quality stock for investors in the Thai capital market.
Today, Northwest Biotherapeutics (OTCQB:NWBO) filed a lawsuit against some of the largest and most influential market makers in the world, including Citadel Securities LLC, Canaccord Genuity LLC, G1 Execution Services LLC (a subsidiary of Susquehanna International Group), GTS Securities LLC, Virtu Americas LLC (including Knight Securities), Instinet LLC, and Score Priority Corp, alleging repeated manipulation of the company’s stock over five years.
Northwest Biotherapeutics, a clinical stage biotechnology company focused on the development of DCVax(R) personalized cancer vaccines, is alleging that these market makers have been engaging in a deceptive market manipulation tactic known as spoofing, which involves placing huge quantities of sell orders to fool the market into devaluing the company’s stock so the market makers can buy at a lower price. The market makers then immediately cancel the sell orders so they can reap profits, in this case to the dismay of current and future cancer patients, as well as at the expense of Northwest Biotherapeutics and its investors. This alleged illegal trading behavior has made it significantly more difficult for the company to raise the funds necessary to bring their cancer treatment to market, where the company believes it has the potential to extend the lives of thousands of patients.
“It’s already underhanded to engage in market manipulation, but to do so at the expense of cancer patients, some of whom have no other treatments to place their hopes on, is unconscionable,” said Laura Posner, Partner at Cohen Milstein Sellers & Toll PLLC. “We’re looking forward to holding these market makers responsible for the harm they have caused, and bringing critical and necessary transparency to these markets.”
Based on the detailed data presented in the complaint, one of the most egregious examples of this behavior occurred on May 10, 2022, at the very moment the topline breakthrough results of the Phase 3 clinical trial of DCVax-L to treat glioblastoma, the most common and aggressive form of brain cancer, were being announced at the prestigious New York Academy of Sciences medical conference. Despite the presentation of significant positive data, the company alleges that during and after the announcement the defendants engaged in extensive spates of spoofing, forcing the company’s stock price down. In a market free from manipulation, the market response should have been strongly positive, not dramatically negative, in response to the positive news. Instead, the result was a $1.6 billion loss in market cap, with the share price dropping from the $2.05 high on May 9 to a low of 36.4 cents on May 10, 2022-a staggering decline of 82%.
Earlier this month, Northwest Biotherapeutics announced the results of this innovative clinical trial for DCVax-L in the prestigious JAMA Oncology journal in a peer reviewed article authored by over 70 brain surgeons and oncologists. The trial results showed that the vaccine was associated with a statistically significant and clinically meaningful life extension for the first time in many years in both newly diagnosed and recurrent glioblastoma, with the potential to more than double 5-year survival, and with almost no serious adverse event side effects. The company believes that this breakthrough vaccine technology may also pave the way for treatments in patients suffering from multiple types of solid tumor cancers.
The spoofing episodes against the company are alleged to have taken place repeatedly over a nearly five-year stretch, sometimes multiple times a day. Northwest Biotherapeutics alleges that it sold over 49 million shares at manipulated and devalued prices as a result of the market makers’ actions. The company believes that the market makers directly impacted the price of Northwest Biotherapeutics’ shares in the market by repeatedly and brazenly manipulating the market through their spoofing, causing Northwest Biotherapeutics to suffer significant losses as it sold millions of shares at artificially depressed prices and was slowed in bringing its encouraging drugs to market.
Northwest Biotherapeutics is represented by national law firm Cohen Milstein Sellers & Toll PLLC.
Northwest Biotherapeutics, Inc is a clinical-stage biotechnology company specializing in developing cutting-edge cancer vaccines that are designed to treat a wide range of solid tumor cancers more effectively than the current treatments on the market and without the side effects of chemotherapy. The company has a broad platform technology for DCVax(R) dendritic cell-based vaccines, including DCVax(R)-L for operable tumors and DCVax(R)-Direct for inoperable tumors. The company’s proprietary manufacturing technology allows efficient and cost-effective production of these innovative vaccines, with the full set of multi-year doses produced in one manufacturing batch and then stored frozen in single doses, making the treatment “off the shelf” throughout the treatment regimen while also being fully personalized. https://nwbio.com/
About Cohen Milstein Sellers & Toll
Cohen Milstein Sellers & Toll PLLC is recognized as one of the premier law firms in the country handling major, complex plaintiff-side litigation. With more than 100 attorneys, Cohen Milstein has offices in Washington, D.C.; Chicago, Ill.; New York, N.Y.; Palm Beach Gardens, Fla.; Philadelphia, Pa.; and Raleigh, N.C. For additional information, visit www.cohenmilstein.com or call 202.408.4600.
Disclaimer
Statements made in this news release that are not historical facts, including statements concerning future treatment of patients using DCVax and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “believe,” “intend,” “design,” “plan,” “continue,” “may,” “will,” “anticipate,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee that we actually will achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results may differ materially from those projected in any forward-looking statement. Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as risks related to the Company’s ability to achieve timely performance of third parties, risks related to whether the Company’s products will demonstrate safety and efficacy, risks related to the Company’s ongoing ability to raise additional capital, and other risks included in the Company’s Securities and Exchange Commission (“SEC”) filings. Additional information on the foregoing risk factors and other factors, including Risk Factors, which could affect the Company’s results, is included in its SEC filings. Finally, there may be other factors not mentioned above or included in the Company’s SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.
Contact
